UA95037U - METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS - Google Patents
METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITISInfo
- Publication number
- UA95037U UA95037U UAU201406708U UAU201406708U UA95037U UA 95037 U UA95037 U UA 95037U UA U201406708 U UAU201406708 U UA U201406708U UA U201406708 U UAU201406708 U UA U201406708U UA 95037 U UA95037 U UA 95037U
- Authority
- UA
- Ukraine
- Prior art keywords
- dose
- day
- drug
- alcoholic
- steatogepatitis
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229960004203 carnitine Drugs 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 230000002443 hepatoprotective effect Effects 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 239000000644 isotonic solution Substances 0.000 abstract 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 abstract 1
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Спосіб лікування неалкогольного стеатогепатиту, який включає застосування гепатопротекторного препарату, причому як гепатопротектор використовують гепадиф у дозі 2 капсули 3 рази на добу (457,2 мг карнітину), додатково застосовують препарат актовегін розчин для інфузій 10 % (1000 мг) 250 мл в ізотонічному розчині протягом 10 діб, з наступним переходом на прийом препарату внутрішньо у дозі 1 таблетка 3 рази на добу (600 мг), та призначають фолієву кислоту у дозі 1 таблетка 2 рази на добу (10 мг), курс терапії становить 1 місяць.A method of treating non-alcoholic steatohepatitis, which involves the use of hepatoprotective drug, and as hepatoprotector use hepatif in a dose of 2 capsules 3 times a day (457.2 mg of carnitine), additionally use the drug actovegin solution for infusion 10% (1000 mg) 250 ml in isotonic solution for 10 days, followed by the intake of the drug internally at a dose of 1 tablet 3 times a day (600 mg), and appoint folic acid at a dose of 1 tablet 2 times a day (10 mg), the course of therapy is 1 month.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201406708U UA95037U (en) | 2014-06-16 | 2014-06-16 | METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201406708U UA95037U (en) | 2014-06-16 | 2014-06-16 | METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA95037U true UA95037U (en) | 2014-12-10 |
Family
ID=52681226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201406708U UA95037U (en) | 2014-06-16 | 2014-06-16 | METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA95037U (en) |
-
2014
- 2014-06-16 UA UAU201406708U patent/UA95037U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201401028A1 (en) | PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY | |
| MX381440B (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCERATIVE COLITIS. | |
| EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
| CY1125499T1 (en) | AZELEIC ACID ESTERS IN THE TREATMENT OF INSULIN RESISTANCE | |
| MX2022000394A (en) | Therapeutic combinations of orally administered paclitaxel and a p-gp inhibitor for the treatment of cancer. | |
| UA95037U (en) | METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS | |
| MX2017006205A (en) | Treatment of enteral feeding intolerance. | |
| RU2012103957A (en) | METHOD OF TREATMENT AND PREVENTION OF NASAL OBSTRUCTION IN PATIENTS WITH POLYZAL RHINOSINUSITIS | |
| RU2012115039A (en) | METHOD FOR TREATING CHRONIC ENDOMETRITIS | |
| UA95834U (en) | Method for treating acute ischemic stroke | |
| UA105586U (en) | Method for treating hepatic encephalopathy | |
| UA99549U (en) | Method for treating symptoms of fatigue in multiple sclerosis | |
| UA95572U (en) | METHOD OF TREATMENT OF REACTIVE NEUROTIC DISORDERS IN CHILDREN WITH DIABETES AND TYPE | |
| UA82717U (en) | Method for treatment of acute ischemic stroke, burdened with ischemic heart disease | |
| MD854Y (en) | Method for treating locally advanced II-III stage cervical canrcinoma | |
| UA108523U (en) | METHOD OF TREATMENT OF PATIENTS WITH EARLY AGAINST POSTINCULAR Dementia | |
| UA120513U (en) | METHOD OF OPTIMIZATION OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS IN PATIENTS WITH ISCHEMIC HEART DISEASE | |
| UA83971U (en) | Method for treatment of hypertensis disease | |
| UA117786U (en) | METHOD OF TREATMENT OF ACUTE ISCHEMIC Stroke | |
| UA106867C2 (en) | Method for correction of neurological disorders in chronic alcohol intoxication | |
| UA96488U (en) | A method for treating disorders of hemovascular hemostasis in patients with ischemic heart disease | |
| UA97011U (en) | METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD | |
| EA201990553A1 (en) | APPLICATION OF PRIDOPIDIN FOR TREATMENT OF FUNCTIONAL ABILITY | |
| UA94167U (en) | Method for improving the treatment of thyrotoxic cardiomyopathy | |
| MD4458B1 (en) | Use of Polybiolin drug in patients with liver cirrhosis |